These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 99528)

  • 21. [The relation of hepatitis B virus to chronic hepatitis, cirrhosis and primary hepatocellar carcinoma--a study of 367 cases of liver biopsy with orcein staining].
    Tang YH
    Zhonghua Nei Ke Za Zhi; 1983 Jan; 22(1):17-20, 62-3. PubMed ID: 6188585
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum complement profile and its clinical significance in patients with hepatocellular carcinoma and liver cirrhosis (author's transl)].
    Matsumura N; Tagami H; Hotta T; Takemura S; Yoshikawa T; Kondo M
    Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1753-9. PubMed ID: 6275149
    [No Abstract]   [Full Text] [Related]  

  • 23. [K-cell activity of peripheral lymphocytes in chronic liver diseases in the light of clinical status and laboratory parameters].
    Garam T; Schnabel R; Csepregi I; Marton E; Pakuts B; Salacz A
    Orv Hetil; 1987 Nov; 128(44):2307-12. PubMed ID: 3684247
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunoglobulins in liver disease.
    Zuberi SJ; Siddiqui M; Lodi TZ
    J Pak Med Assoc; 1977 Sep; 27(9):391-2. PubMed ID: 416244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Some current problems in hepatic immunopathology].
    Banciu T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):405-12. PubMed ID: 44563
    [No Abstract]   [Full Text] [Related]  

  • 26. The serum concentration of the third component of complement beta-1C-beta-1A in liver disease.
    Fox RA; Dudley FJ; Sherlock S
    Gut; 1971 Jul; 12(7):574-8. PubMed ID: 4997691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Australia antigen in liver disease in Zambia.
    Lowenthal M; Banatvala JE; Chrystie IL; Jones IG; Nag J; Mohelsky V; Hutt MS
    Trop Geogr Med; 1973 Mar; 25(1):39-44. PubMed ID: 4348424
    [No Abstract]   [Full Text] [Related]  

  • 28. [Detection of HBxAG in the liver tissue of patients with chronic liver diseases and its significance].
    Hu KQ; Hao LJ; Wang YK
    Zhonghua Nei Ke Za Zhi; 1988 Jun; 27(6):355-7, 390. PubMed ID: 3058423
    [No Abstract]   [Full Text] [Related]  

  • 29. [Indicators of nonspecific immunity in cirrhosis and primary cancer of the liver].
    Afanas'eva KA; Afanas'ev SS; Ablaeva TD; Podobedov GM
    Vopr Onkol; 1976; 22(12):21-4. PubMed ID: 1020251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg).
    Omata M; Afroudakis A; Liew CT; Ashcavai M; Peters RL
    Gastroenterology; 1978 Dec; 75(6):1003-9. PubMed ID: 710851
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence of hepatitis associated antigen in chronic liver disease in Southern Italy.
    Del Vecchio-Blanco C; Carrella M; Coltorti M
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):138-42. PubMed ID: 4356375
    [No Abstract]   [Full Text] [Related]  

  • 32. Carcinoembryonic antigen and the liver.
    Loewenstein MS; Zamcheck N
    Gastroenterology; 1977 Jan; 72(1):161-6. PubMed ID: 830231
    [No Abstract]   [Full Text] [Related]  

  • 33. The HLA system: its relevance to the pathogenesis of liver disease.
    Thomas HC; Shipton U; Montanó L
    Prog Liver Dis; 1982; 7():517-27. PubMed ID: 6955893
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis-associated antigen in liver diseases.
    Chang CK; Shih PL; Sung JL
    Taiwan Yi Xue Hui Za Zhi; 1972 Mar; 71(3):146-59. PubMed ID: 4341745
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
    Libman E; Stojsić S; Marton B; Lemberger J
    Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636
    [No Abstract]   [Full Text] [Related]  

  • 36. OMGE--Study on prevalence of hepatitis B surface antigen in different liver diseases.
    Wewalka F; Hadziyannis S; Pesendorfer FX; Dragosics B; Base W
    Scand J Gastroenterol Suppl; 1979; 56():55-68. PubMed ID: 94455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of circulating immune complexes in chronic hepatopathies].
    Delsignore R; Baroni MC; Mineo F; Conversi E; Campana G; Butturini U
    G Clin Med; 1984; 65(9-10):389-94. PubMed ID: 6530118
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnostic significance of autoantibodies present in the blood of patients with liver diseases].
    Barabino A; Di Benedetto G; Indiveri F; Molinelli G; Puppo F; Soldà AM
    Arch Maragliano Patol Clin; 1974; 30(1):13-21. PubMed ID: 4480694
    [No Abstract]   [Full Text] [Related]  

  • 39. [Australia antigen in various liver diseases (except acute hepatitis). 3].
    Migneco G; Mansueto S; Tripi S
    G Mal Infett Parassit; 1971 Dec; 23(12):1125-6. PubMed ID: 5151318
    [No Abstract]   [Full Text] [Related]  

  • 40. [Monoclonal immunoglobulins in chronic liver diseases].
    Zimmermann S; Kratzsch KH; Lewicki I
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):135-6. PubMed ID: 1021380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.